Cargando…
Cost of treating inpatient falciparum malaria on the Thai-Myanmar border
BACKGROUND: Despite demonstrated benefits and World Health Organization (WHO) endorsement, parenteral artesunate is the recommended treatment for patients with severe Plasmodium falciparum malaria in only one fifth of endemic countries. One possible reason for this slow uptake is that a treatment co...
Autores principales: | Kyaw, Shwe Sin, Drake, Tom, Ruangveerayuth, Ronatrai, Chierakul, Wirongrong, White, Nicholas J, Newton, Paul N, Lubell, Yoel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4218997/ https://www.ncbi.nlm.nih.gov/pubmed/25351915 http://dx.doi.org/10.1186/1475-2875-13-416 |
Ejemplares similares
-
Cost effectiveness and resource allocation of Plasmodium falciparum malaria control in Myanmar: a modelling analysis of bed nets and community health workers
por: Drake, Tom L., et al.
Publicado: (2015) -
Malaria community health workers in Myanmar: a cost analysis
por: Kyaw, Shwe Sin, et al.
Publicado: (2016) -
Estimating the programmatic cost of targeted mass drug administration for malaria in Myanmar
por: Kyaw, Shwe Sin, et al.
Publicado: (2021) -
Clinical diagnosis of malaria on the Thai-Myanmar border.
por: Hu, K. K., et al.
Publicado: (2001) -
Poor response to artesunate treatment in two patients with severe malaria on the Thai–Myanmar border
por: Phyo, Aung Pyae, et al.
Publicado: (2018)